Transatlantique Private Wealth LLC Has $1.38 Million Stock Holdings in Danaher Corporation $DHR

Transatlantique Private Wealth LLC lifted its holdings in Danaher Corporation (NYSE:DHR) by 98.1% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 6,037 shares of the conglomerate’s stock after purchasing an additional 2,989 shares during the quarter. Transatlantique Private Wealth LLC’s holdings in Danaher were worth $1,382,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in DHR. JPL Wealth Management LLC bought a new position in shares of Danaher in the third quarter valued at about $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter valued at about $26,000. WFA of San Diego LLC bought a new stake in Danaher during the 2nd quarter worth about $26,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher during the 3rd quarter worth about $27,000. Finally, Financial Life Planners bought a new stake in Danaher during the 3rd quarter worth about $32,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

Shares of DHR stock opened at $178.40 on Thursday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock has a market cap of $126.26 billion, a PE ratio of 34.51, a price-to-earnings-growth ratio of 2.35 and a beta of 0.81. The stock has a 50-day moving average of $181.40 and a 200-day moving average of $206.59. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.88 EPS. As a group, sell-side analysts expect that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s payout ratio is currently 30.95%.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent research reports. The Goldman Sachs Group dropped their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Royal Bank Of Canada initiated coverage on Danaher in a research report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price target on the stock. Argus reduced their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. DZ Bank started coverage on Danaher in a research note on Wednesday. They issued a “buy” rating and a $210.00 price target for the company. Finally, Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. Twenty investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $235.14.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.